Armata Pharmaceuticals (ARMP) Exchange Rate Effect (2013 - 2014)
Armata Pharmaceuticals (ARMP) reported Exchange Rate Effect of -$93000.0 for Q3 2014, down 342.86% on a YoY basis from $38294.1 in Q3 2013, and down 481.25% sequentially from -$16000.0 in Q2 2014.
Armata Pharmaceuticals (ARMP) Exchange Rate Effect (2013 - 2014) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 2 years of Exchange Rate Effect data on file, last reported at -$93000.0 in Q3 2014.
- For the quarter ending Q3 2014, Exchange Rate Effect fell 342.86% year-over-year to -$93000.0; the trailing twelve-month figure through Sep 2014 stood at -$96000.0 (changed N/A YoY), and the FY2013 full-year result was $41000.0, changed N/A from the prior year.
- Exchange Rate Effect fell to -$93000.0 in Q3 2014, from -$16000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $158000.0 in Q2 2013 to a low of -$113000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | -93,000.00 |
| Sep 30, 2014 | -93,000.00 |
| Jun 30, 2014 | -16,000.00 |
| Jun 30, 2014 | -16,000.00 |
| Mar 31, 2014 | -4,000.00 |
| Mar 31, 2014 | -4,000.00 |
| Dec 31, 2013 | 17,000.00 |
| Dec 31, 2013 | 17,000.00 |
| Sep 30, 2013 | -21,000.00 |
| Sep 30, 2013 | -21,000.00 |
| Jun 30, 2013 | 158,000.00 |
| Jun 30, 2013 | 158,000.00 |
| Mar 31, 2013 | -113,000.00 |
| Mar 31, 2013 | -113,000.00 |